Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104151352B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104151352B reveals a high-purity Sofosbuvir intermediate method. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.